Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
1.
J Reprod Med ; 56(7-8): 313-20, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21838161

RESUMO

OBJECTIVE: To identify risk factors associated with uterine rupture among term pregnancies attempting a vaginal birth after a previous cesarean. STUDY DESIGN: A case-control study was done of 348 uterine ruptures in Massachusetts between 1991 and 1998, initially screened by ICD-9 code and confirmed by medical record review, with 424 control women with a trial of labor randomly selected proportional to cases on year of delivery. Multivariable regression was used to estimate odds ratios and 95% confidence intervals. RESULTS: Successful previous vaginal birth decreased risk for uterine rupture, and gestation > 40 weeks and macrosomia increased risk. Oxytocin for induction increased risk, with a slightly lower effect when used for augmentation. Prostaglandin use in conjunction with oxytocin did not have an additive uterine rupture risk. Women using epidural analgesia have an increased uterine rupture risk. CONCLUSION: Certain labor management practices increase the risk for uterine rupture 2-3 times, although the absolute increase is small from a baseline uterine rupture rate of 0.5% to 1.0-1.5%. The association between epidural analgesia and uterine rupture deserves further study.


Assuntos
Anestesia Epidural/efeitos adversos , Resultado da Gravidez/epidemiologia , Ruptura Uterina/epidemiologia , Nascimento Vaginal Após Cesárea/estatística & dados numéricos , Adulto , Anestesia Epidural/estatística & dados numéricos , Estudos de Casos e Controles , Cesárea/estatística & dados numéricos , Feminino , Humanos , Incidência , Recém-Nascido , Massachusetts/epidemiologia , Ocitocina/administração & dosagem , Assistência Perinatal/métodos , Valor Preditivo dos Testes , Gravidez , Fatores de Risco , Prova de Trabalho de Parto , Ruptura Uterina/etiologia , Nascimento Vaginal Após Cesárea/efeitos adversos , Saúde da Mulher , Adulto Jovem
2.
Obstet Gynecol ; 113(2 Pt 2): 548-550, 2009 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-19155952

RESUMO

BACKGROUND: Cervical cone biopsy or loop electrosurgical excision procedures (LEEP) may lead to cervical scarring, agglutination, or stenosis. Leiomyomas may also obstruct the lower uterine segment such that instruments cannot be passed from the vagina to the gestation. CASE: Two women requested second trimester abortion. Both women had undergone cervical LEEP. In addition, one woman had a 10-cm leiomyoma, which seemed to be obstructing the lower segment. In both, the external cervical os was essentially obliterated. After administration of misoprostol, the cervix softened markedly in 18-24 hours. In both women, the cervix dilated readily and allowed dilation and evacuation of the uterus. CONCLUSION: Misoprostol resulted in the ability to evacuate the uterus vaginally, in a situation that might have otherwise resulted in hysterotomy.


Assuntos
Aborto Induzido/métodos , Colo do Útero/patologia , Segundo Trimestre da Gravidez , Curetagem a Vácuo , Abortivos não Esteroides/uso terapêutico , Cerclagem Cervical/efeitos adversos , Conização/efeitos adversos , Feminino , Humanos , Misoprostol/uso terapêutico , Gravidez
3.
Am J Obstet Gynecol ; 199(6 Suppl 2): S259-65, 2008 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-19081420

RESUMO

Scientific evidence indicates that improving a woman's health before pregnancy will improve pregnancy outcomes. However, for many years, our efforts have focused primarily on prenatal care and on caring for infants after birth. The concept of preconception care has been identified repeatedly as a priority for improving maternal and infant health. Preconception care is not something new that is being added to the already overburdened healthcare provider, but it is a part of routine primary care for women of reproductive age. Many opportunities exist for preconception intervention, and much of preconception care involves merely the provider reframing his or her thinking, counseling, and decisions in light of the reproductive plans and sexual and contraceptive practices of the patient. With existing scientific evidence that improving the health of "W"omen will improve the health of mothers and children, we must focus on improving the health of "W"omen before pregnancy and put the "W" in Maternal and Child Health.


Assuntos
Atenção à Saúde , Cuidado Pré-Concepcional , Saúde da Mulher , Centers for Disease Control and Prevention, U.S. , Criança , Proteção da Criança , Feminino , Humanos , Masculino , Bem-Estar Materno , Gravidez , Estados Unidos
4.
Am J Obstet Gynecol ; 199(6 Suppl 2): S296-309, 2008 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-19081424

RESUMO

A number of infectious diseases should be considered for inclusion as part of clinical preconception care. Those infections strongly recommended for health promotion messages and risk assessment or for the initiation of interventions include Chlamydia infection, syphilis, and HIV. For selected populations, the inclusion of interventions for tuberculosis, gonorrheal infection, and herpes simplex virus are recommended. No clear evidence exists for the specific inclusion in preconception care of hepatitis C, toxoplasmosis, cytomegalovirus, listeriosis, malaria, periodontal disease, and bacterial vaginosis (in those with a previous preterm birth). Some infections that have important consequences during pregnancy, such as bacterial vaginosis (in those with no history of preterm birth), asymptomatic bacteriuria, parvovirus, and group B streptococcus infection, most likely would not be improved through intervention in the preconception time frame.


Assuntos
Infecções Bacterianas/prevenção & controle , Doenças Parasitárias/prevenção & controle , Cuidado Pré-Concepcional , Complicações Infecciosas na Gravidez/prevenção & controle , Viroses/prevenção & controle , Feminino , Humanos , Gravidez , Cuidado Pré-Natal
5.
Am J Obstet Gynecol ; 199(6 Suppl 2): S373-83, 2008 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-19081433

RESUMO

A history of previous birth of a low birthweight infant, previous cesarean sections, multiple previous spontaneous abortions, prior stillbirth, or uterine anomaly identifies women at increased risk for recurrent abortion, preterm birth, or stillbirth. We review the evidence for the potential benefit of reproductive history in identifying strategies for evaluation and treatment to prevent recurrent adverse pregnancy outcome. We offer evidence-based recommendations for management of women with these histories.


Assuntos
Cuidado Pré-Concepcional , Complicações na Gravidez/prevenção & controle , História Reprodutiva , Feminino , Humanos , Gravidez , Resultado da Gravidez
6.
Hum Genet ; 123(4): 359-69, 2008 May.
Artigo em Inglês | MEDLINE | ID: mdl-18320229

RESUMO

Preterm delivery (PTD, <37 weeks of gestation) is a significant clinical and public health problem. Previously, we reported that maternal smoking and metabolic gene polymorphisms of CYP1A1 MspI and GSTT1 synergistically increase the risk of low birth weight. This study investigates the relationship between maternal smoking and metabolic gene polymorphisms of CYP1A1 MspI and GSTT1 with preterm delivery (PTD) as a whole and preterm subgroups. This case-control study included 1,749 multi-ethnic mothers (571 with PTD and 1,178 controls) enrolled at Boston Medical Center. After adjusting covariates, regression analyses were performed to identify individual and joint associations of maternal smoking, two functional variants of CYP1A1 and GSTT1 with PTD. We observed a moderate effect of maternal smoking on PTD (OR = 1.6; 95% CI: 1.1-2.2). We found that compared to non-smoking mothers with low-risk genotypes, there was a significant joint association of maternal smoking, CYP1A1 (Aa/aa) and GSTT1 (absent) genotypes with gestational age (beta = -3.37; SE = 0.86; P = 9 x 10(-5)) and with PTD (OR = 5.8; 95% CI: 2.0-21.1), respectively. Such joint association was particularly strong in certain preterm subgroups, including spontaneous PTD (OR = 8.3; 95% CI: 2.7-30.6), PTD < 32 weeks (OR = 11.1; 95% CI: 2.9-47.7), and PTD accompanied by histologic chorioamnionitis (OR = 15.6; 95% CI: 4.1-76.7). Similar patterns were observed across ethnic groups. Taken together, maternal smoking significantly increased the risk of PTD among women with high-risk CYP1A1 and GSTT1 genotypes. Such joint associations were strongest among PTD accompanied by histologic chorioamnionitis.


Assuntos
Metabolismo/genética , Polimorfismo Genético , Nascimento Prematuro/etiologia , Nascimento Prematuro/genética , Fumar/efeitos adversos , Fumar/genética , Adulto , Sequência de Bases , Estudos de Casos e Controles , Corioamnionite/enzimologia , Corioamnionite/etiologia , Corioamnionite/genética , Citocromo P-450 CYP1A1/genética , Primers do DNA/genética , Feminino , Genótipo , Glutationa Transferase/genética , Humanos , Recém-Nascido , Razão de Chances , Gravidez , Nascimento Prematuro/enzimologia , Análise de Regressão , Fumar/metabolismo
7.
Matern Child Health J ; 10(1): 39-46, 2006 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-16397832

RESUMO

BACKGROUND: The rate of low birth weight (LBW) of Black women is more than twice that of White women. This study explores if the rate of LBW differs between Haitian and African-American women with chronic hypertension. METHODS: A retrospective cohort study of all Black women self-identified as African-American (n = 12,258) or Haitian (n = 4320) delivering a singleton infant in Massachusetts between 1996 and 2000. RESULTS: Haitian women were more likely than African-American women to have chronic hypertension (2.7% vs. 2.1%, p = 0.006), but had similar rates of preeclampsia (3.1% vs. 3.3%, p = 0.27). The LBW rate was 10% among African-American women and 8.2% among Haitian women. After adjustment for sociodemographic, medical, and prenatal care characteristics, the greatest risks for delivering a LBW infant for Haitian women were chronic hypertension (OR = 6.8; 95% CI, 4.3, 10.6) and preeclampsia (OR = 3.2; 95% CI, 2.0, 5.1). For African-American women, the greatest risks for LBW infants were a history of delivering a LBW infant (OR = 3.9; 95% CI, 2.8, 5.4) and chronic hypertension (OR = 2.9; 95% CI, 2.1, 4.0). In a combined logistic regression model including interaction terms, chronic hypertension and preeclampsia continued to be associated with the greatest risk of LBW among all women. CONCLUSIONS: Differences in maternal risk factors and rates of LBW (8.2% vs. 10%) exist between Haitian and African-American women delivering infants in Massachusetts. While chronic hypertension and preeclampsia are strong risk factors for LBW for both Haitian and African-American women, unknown factors make these disorders much more potent for Haitian women.


Assuntos
Negro ou Afro-Americano/estatística & dados numéricos , Hispânico ou Latino/estatística & dados numéricos , Hipertensão Induzida pela Gravidez/etnologia , Recém-Nascido de Baixo Peso , Complicações Cardiovasculares na Gravidez/etnologia , Adulto , Negro ou Afro-Americano/classificação , Negro ou Afro-Americano/etnologia , Doença Crônica , Feminino , Haiti/etnologia , Humanos , Hipertensão/epidemiologia , Hipertensão/etnologia , Hipertensão Induzida pela Gravidez/epidemiologia , Recém-Nascido , Modelos Logísticos , Massachusetts/epidemiologia , Pré-Eclâmpsia/epidemiologia , Pré-Eclâmpsia/etnologia , Gravidez , Complicações Cardiovasculares na Gravidez/epidemiologia , Medição de Risco , Fatores de Risco
8.
Contraception ; 72(5): 358-61, 2005 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-16246662

RESUMO

OBJECTIVE: To compare the outcomes of second-trimester induction abortion with misoprostol and hypertonic saline, with and without use of laminaria. METHOD: Fifty-eight women, between 17.5 and 22.5 weeks' gestation, were randomly assigned to receive or omit laminaria in conjunction with other procedures for induction abortion. All women received a fetocidal dose of 60 cc intra-amniotic hypertonic saline. If the woman was to receive laminaria, they were inserted next. This was followed by vaginal misoprostol 200 mug, which was repeated every 6 h. RESULT: Women with laminaria inserted before misoprostol administration had longer intervals from start of misoprostol to delivery of the fetus (induction times) than women without laminaria. Induction time was 14.4 vs. 11.4 h, respectively (p=.04, Wilcoxon rank sum test). Total misoprostol use was higher in the laminaria group, 628 mug (95% CI, 516-738) vs. 496 mug (95% CI, 419-573) (p=.05). Total analgesic use was also higher in the laminaria group, 41 mg of morphine (95% CI, 32-50) vs. 26 mg of morphine (95% CI, 18-32) (p=.02). CONCLUSION: Laminaria use, in conjunction with misoprostol and hypertonic saline, significantly prolongs induction time and increases narcotic analgesia usage.


Assuntos
Abortivos não Esteroides/administração & dosagem , Aborto Induzido , Laminaria , Misoprostol/administração & dosagem , Administração Intravaginal , Adulto , Feminino , Idade Gestacional , Humanos , Gravidez , Segundo Trimestre da Gravidez , Fatores de Tempo
9.
Obstet Gynecol ; 104(1): 174-85, 2004 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-15229018

RESUMO

We describe present methods for induced abortion used in the United States. The most common procedure is first-trimester vacuum curettage. Analgesia is usually provided with a paracervical block and is not completely effective. Pretreatment with nonsteroidal analgesics and conscious sedation augment analgesia but only to a modest extent. Cervical dilation is accomplished with conventional tapered dilators, hygroscopic dilators, or misoprostol. Manual vacuum curettage is as safe and effective as the electric uterine aspirator for procedures through 10 weeks of gestation. Common complications and their management are presented. Early abortion with mifepristone/misoprostol combinations is replacing some surgical abortions. Two mifepristone/misoprostol regimens are used. The rare serious complications of medical abortion are described. Twelve percent of abortions are performed in the second trimester, the majority of these by dilation and evacuation (D&E) after laminaria dilation of the cervix. Uterine evacuation is accomplished with heavy ovum forceps augmented by 14-16 mm vacuum cannula systems. Cervical injection of dilute vasopressin reduces blood loss. Operative ultrasonography is reported to reduce perforation risk of D&E. Dilation and evacuation procedures have evolved to include intact D&E and combination methods for more advanced gestations. Vaginal misoprostol is as effective as dinoprostone for second-trimester labor-induction abortion and appears to be replacing older methods. Mifepristone/misoprostol combinations appear more effective than misoprostol alone. Uterine rupture has been reported in women with uterine scars with misoprostol abortion in the second trimester. Fetal intracardiac injection to reduce multiple pregnancies or selectively abort an anomalous twin is accepted therapy. Outcomes for the remaining pregnancy have improved with experience.


Assuntos
Aborto Induzido/métodos , Dilatação , Feminino , Humanos , Trabalho de Parto Induzido/métodos , Gravidez , Primeiro Trimestre da Gravidez , Segundo Trimestre da Gravidez , Curetagem a Vácuo
12.
Obstet Gynecol Clin North Am ; 29(3): 495-510, 2002 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-12353670

RESUMO

In summary, FDA-approved therapies for prevention and treatment of osteoporosis are all antiresorptive agents. There are no approved therapies at this time that stimulate bone formation, although one such agent (PTH) is awaiting approval. Screening perimenopausal women at risk should identify osteopenic women early in the menopause before the accelerated bone loss of estrogen deficiency causes further irreversible erosion in bone density. The National Osteoporosis Foundation advocates initiating therapy to reduce fracture risk in postmenopausal women with T scores below -2 in the absence or factors and with T scores below -1.5 if other risk factors are present. Estrogen, alendronate, residronate, and raloxifene have all been shown to reduce the incidence of radiographic vertebral fractures in women at risk. Only alendronate and residronate have been shown in large randomized trials to reduce the incidence of nonvertebral fractures including hip fractures in women with postmenopausal osteoporosis. These antiresorptive therapies provide benefits above and beyond those of calcium and vitamin D alone. There is insufficient published evidence from randomized controlled trials convincingly to support a role for soy products, androgens, calcitonin, or fluoride in prevention of postmenopausal osteoporosis or reduction of fracture rates in women at risk.


Assuntos
Densidade Óssea , Climatério/fisiologia , Programas de Rastreamento , Osteoporose/diagnóstico , Osteoporose/prevenção & controle , Reabsorção Óssea/prevenção & controle , Osso e Ossos/metabolismo , Feminino , Humanos , Fatores de Risco
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...